Pre-filled Syringes, Injectable Drug Devices & Parenteral Systems
Pre-filled Syringes, Injectable Drug Devices & Parenteral Systems
InjectaSummit is the premier event uniting professionals from the pharmaceutical, medical device, and healthcare sectors in an exploration of the latest advancements in pre-filled syringes, injectable drug devices, and parenteral systems. Our summit is a vital hub for industry experts, decision-makers, and innovators to exchange insights, discuss regulatory compliance, delve into patient-centric design, explore emerging technologies, and address sustainability. It’s where professionals learn, network, and collaborate with leaders in these fields. Join us in beautiful Barcelona on June 27-28, 2024, and be part of the conversation that’s shaping the future of injectable drug delivery.
Chief Executive Officer at Windgap Medical
I am privileged to be the CEO of Windgap Medical, a privately-held drug delivery company
focused on solutions which simplify, automate, and accelerate the delivery of difficult-to-mix
drugs. Our solutions free patients, families, and complex therapies from the limitations of
current delivery systems. In partnership with leading biopharmaceutical companies, we are
working to bring these solutions to patients.
Previously, I was CEO at Kindeva Drug Delivery, a leading global CDMO to
biopharmaceutical companies, with over 1000 talented colleagues, which was spun out of 3M
in 2020, backed by Altaris Capital Partners. Kindeva's capabilities span inhalation,
transdermal and microneedles, from pre-clinical work, through regulatory processes and
approval, into commercial scale and supply with sites in the US and the UK. Through
COVID and over the course of two years we fully separated the business from 3M and
established a clean, global, modern set of systems and processes.
At 3M, I led the Drug Delivery Systems business, a global leader in the contract formulation,
development, and manufacturing of delivery systems for complex molecules. I also held
responsibility for strategy and business development for the Health Care Business Group,
completing ~$8B of transactions. Key accomplishments include the acquisitions of Acelity
(wound care) and mModal (health IT).
Earlier, I ran corporate development, strategy, and marketing at Phillips-Medisize, a Molex
company. Phillips-Medisize is a global contract designer and manufacturer of drug delivery
and medical device products Golden Gate Capital sold Phillips-Medisize to Molex and Koch
Industries in October 2016. I've also led Operations at Remedi Senior Care, a Centerbridge
Partners portfolio company. Remedi, an institutional pharmacy, was built around a
proprietary high-speed automated dispensing system, serving over 30,000 long-term care
residents from 6 pharmacies 24x7x365.
I began my career at Bain & Company, spending significant time across four continents and
multiple industries and wide range of capabilities. I graduated from the Harvard Business
School and Carleton College.
Director, Front End Innovation at Phillips-Medisize
Bjarne Sørensen is a director of front-end innovation at Phillips-Medisize, based in the
company’s development centre in Denmark.
With more than 35 years of experience within product, strategy, and business development,
Bjarne has a very visible track record within different business areas. At Phillips-Medisize, he
participates in customer projects, typically involving electronic injectors and connected health
systems. He is also deeply involved in new electronic platform programs, especially on
conceptual, technical, and sustainability aspects.
Director Senior Expert Nonclinical Safety Bayer AG
Access Exclusive Resources
Highlight your groundbreaking research and innovations by becoming an exhibitor at InjectaSummit. Inquire today for showcase opportunities.
C/ de Pau Claris, 122, L’Eixample, 08009 Barcelona
Spain
